Dong Wang
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 0.5%
- Metal complexes synthesis and properties
Papers in
-
- Epigenetics and DNA Methylation 24
- RNA modifications and cancer 24
- Circular RNAs in diseases 21
- Natural product bioactivities and synthesis 19
-
- Cancer-related molecular mechanisms research 38
- Cancer, Hypoxia, and Metabolism 21
- Co-authors
- Stephen J. Lippard (1 shared paper)Xiao Zhang (1 shared paper)Andrea Baccarelli (1 shared paper)Lifang Hou (1 shared paper)Roger D. Kornberg (1 shared paper)Kenneth D. Westover (1 shared paper)Craig D. Kaplan (1 shared paper)David Bushnell (1 shared paper)
- Journals
- Frontiers in Immunology (11 papers)Frontiers in Oncology (8 papers)Frontiers in Pharmacology (8 papers)Frontiers in Microbiology (8 papers)Oncotarget (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dong Wang
527 papers receiving 16.0k citations
Dong Wang's Hit Papers
Peers
Comparison fields: 5 of 184
- Cancer Research 2.4k
- Oncology 3.5k
- Molecular Biology 7.7k
- Immunology 1.7k
- Pathology and Forensic Medicine 834
Countries citing papers authored by Dong Wang
This map shows the geographic impact of Dong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Wang more than expected).
Fields of papers citing papers by Dong Wang
This network shows the impact of papers produced by Dong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Wang. The network helps show where Dong Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 549 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cellular processing of platinum anticancer drugs Hit paper breakdown → | 2005 | 3225 |
| 2 | Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA Hit paper breakdown → | 2011 | 656 |
| 3 | Structural Basis of Transcription: Role of the Trigger Loop in Substrate Specificity and Catalysis Hit paper breakdown → | 2006 | 382 |
| 4 | 2015 | 360 | |
| 5 | Dendritic cell biology and its role in tumor immunotherapy Hit paper breakdown → | 2020 | 338 |
| 6 | 2011 | 328 | |
| 7 | 2016 | 317 | |
| 8 | 2012 | 186 | |
| 9 | 2018 | 171 | |
| 10 | 2015 | 167 | |
| 11 | 2003 | 162 | |
| 12 | 2019 | 154 | |
| 13 | 2019 | 145 | |
| 14 | 2020 | 142 | |
| 15 | 2020 | 125 | |
| 16 | 2020 | 123 | |
| 17 | 2022 | 121 | |
| 18 | 2008 | 119 | |
| 19 | 2018 | 116 | |
| 20 | 2003 | 112 |
About Dong Wang
Dong Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 549 papers that have together received 16.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (38 papers), Epigenetics and DNA Methylation (24 papers), RNA modifications and cancer (24 papers), Computational Drug Discovery Methods (22 papers), Circular RNAs in diseases (21 papers), Cancer, Hypoxia, and Metabolism (21 papers), Ferroptosis and cancer prognosis (20 papers) and Natural product bioactivities and synthesis (19 papers). The work is most often cited by research in Cancer Research (2.4k citations), Oncology (3.5k citations), Molecular Biology (7.7k citations), Immunology (1.7k citations) and Pathology and Forensic Medicine (834 citations). Dong Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Stephen J. Lippard, Xiao Zhang, Andrea Baccarelli, Lifang Hou, Roger D. Kornberg, Kenneth D. Westover, Craig D. Kaplan, David Bushnell, Ivan García-Bassets and Christopher K. Glass. Their work appears in journals such as Frontiers in Immunology, Frontiers in Oncology, Frontiers in Pharmacology, Frontiers in Microbiology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.